IL62621A0 - Substituted 1-(alpha-aminocarbonylbenzyl)-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted 1-(alpha-aminocarbonylbenzyl)-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL62621A0
IL62621A0 IL62621A IL6262181A IL62621A0 IL 62621 A0 IL62621 A0 IL 62621A0 IL 62621 A IL62621 A IL 62621A IL 6262181 A IL6262181 A IL 6262181A IL 62621 A0 IL62621 A0 IL 62621A0
Authority
IL
Israel
Prior art keywords
aminocarbonylbenzyl
dihydroisoquinolines
alpha
substituted
preparation
Prior art date
Application number
IL62621A
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL62621A0 publication Critical patent/IL62621A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65C—LABELLING OR TAGGING MACHINES, APPARATUS, OR PROCESSES
    • B65C2210/00—Details of manually controlled or manually operable label dispensers
    • B65C2210/0037—Printing equipment
    • B65C2210/004—Printing equipment using printing heads
    • B65C2210/0045—Printing equipment using printing heads mechanically actuated, e.g. by a hand lever
IL62621A 1980-04-11 1981-04-09 Substituted 1-(alpha-aminocarbonylbenzyl)-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them IL62621A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803013906 DE3013906A1 (de) 1980-04-11 1980-04-11 Substituierte (alpha) -aminocarbonyl-l-benzyl-3,4-dihydro-isochinoline, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
IL62621A0 true IL62621A0 (en) 1981-06-29

Family

ID=6099734

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62621A IL62621A0 (en) 1980-04-11 1981-04-09 Substituted 1-(alpha-aminocarbonylbenzyl)-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4322418A (xx)
EP (1) EP0037934A3 (xx)
JP (1) JPS56158765A (xx)
AU (1) AU6938481A (xx)
DE (1) DE3013906A1 (xx)
DK (1) DK164281A (xx)
ES (1) ES8707502A1 (xx)
FI (1) FI811123L (xx)
GB (1) GB2074159A (xx)
GR (1) GR74904B (xx)
HU (1) HU183394B (xx)
IL (1) IL62621A0 (xx)
NO (1) NO811245L (xx)
NZ (1) NZ196788A (xx)
PT (1) PT72832B (xx)
YU (1) YU94181A (xx)
ZA (1) ZA812391B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (de) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung
DE3621413A1 (de) * 1986-06-26 1988-01-07 Boehringer Ingelheim Kg Verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine als cardioprotektive mittel sowie neue heterocyclisch und carbocyclisch anellierte dihydropyridine, verfahren zu deren herstellung und zwischenstufen fuer deren herstellung
IL86131A0 (en) * 1987-04-24 1988-11-15 Boehringer Ingelheim Kg Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3827727A1 (de) * 1988-08-16 1990-02-22 Boehringer Ingelheim Kg Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion
DE9017900U1 (xx) 1990-12-22 1993-01-28 Boehringer Ingelheim Kg, 6507 Ingelheim, De
US5643919A (en) * 1992-06-22 1997-07-01 Boehringer Ingelheim Kg Anellated dihydropyridines and the use thereof for the production of pharmaceutical preparation
CA2138788A1 (en) * 1992-06-22 1994-01-06 Dietrich Arndts Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
CN1056832C (zh) * 1992-06-22 2000-09-27 贝林格尔·英格海姆公司 稠合二氢吡啶衍生物及其制法和含有其的药物组合物
PT590455E (pt) * 1992-09-28 2001-04-30 Hoechst Ag 1(2h)-isoquinolinas substituidas anti-arritmicas e cardioprotectoras processo para a sua preparacao medicamento contendo estes compostos e sua utilizacao para a preparacao de um medicamento para o combate de falhas cardiacas
CN1138324A (zh) 1993-12-21 1996-12-18 贝林格尔·英格海姆公司 增环的二氢吡啶及其在制备药物制剂中的应用
DE4343683A1 (de) * 1993-12-21 1995-06-22 Boehringer Ingelheim Kg Anellierte Dihydropyridine und deren Verwendung für die Herstellung von pharmazeutischen Zubereitungen
ATE506343T1 (de) * 2007-03-15 2011-05-15 Hoffmann La Roche Malonamide als orexin-antagonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2769810A (en) * 1955-08-15 1956-11-06 Shionogi & Co Process for preparing hydroxy-n-methylmorphinan
US3207759A (en) * 1962-08-01 1965-09-21 Hoffmann La Roche Isoquinoline acetamides and acetonitriles
JPS5242886A (en) * 1975-10-02 1977-04-04 Takeda Chem Ind Ltd Preparation of esoquinoline compounds

Also Published As

Publication number Publication date
NZ196788A (en) 1983-05-10
EP0037934A2 (de) 1981-10-21
YU94181A (en) 1983-04-30
DE3013906A1 (de) 1981-10-15
DK164281A (da) 1981-10-12
GR74904B (xx) 1984-07-12
AU6938481A (en) 1981-10-29
JPS56158765A (en) 1981-12-07
FI811123L (fi) 1981-10-12
ES8707502A1 (es) 1986-04-16
ES501245A0 (es) 1986-04-16
NO811245L (no) 1981-10-12
PT72832B (de) 1983-01-10
PT72832A (de) 1981-05-01
ZA812391B (en) 1982-12-29
HU183394B (en) 1984-04-28
EP0037934A3 (de) 1982-05-12
GB2074159A (en) 1981-10-28
US4322418A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
IL64665A (en) 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL64504A0 (en) Pyrimidones,their preparation and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
DE3167679D1 (en) Pharmaceutical forms, their preparation and compositions containing the same
IL61968A0 (en) 1-(cycolohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ZA816844B (en) Substituted iminodiacids,their preparation and pharmaceutical compositions containing them
IL62621A0 (en) Substituted 1-(alpha-aminocarbonylbenzyl)-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them
IL64498A0 (en) Phenylalkylamines,their preparation and pharmaceutical compositions containing them
DE3169095D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL62320A0 (en) 1-(4-aryl-cyclohexyl)piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL73425A0 (en) 1-(2-aryl-2-halo-1-ethenyl)-1h-azoles,their preparation and pharmaceutical compositions containing them
IL63245A0 (en) 3-aminopropoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
IL65177A0 (en) Fluoroprostacylins,their preparation and pharmaceutical compositions containing them
IL62970A0 (en) Substituted phenoxy-aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
IL62606A0 (en) Pyrrolylpiperidines,their preparation and pharmaceutical compositions containing them
IL63174A0 (en) Dibenzindole derivatives,their preparation and pharmaceutical compositions containing them
IL62116A (en) Benzylidenimine derivatives,their preparation and pharmaceutical compositions containing them
IL63369A (en) 13-oxa-prostaglandin derivatives,their preparation and pharmaceutical compositions containing them
IL62223A0 (en) Isoquinoline derivatives,their manufacture and pharmaceutical compositions containing them
IL63246A0 (en) Pyridinyl-amino-phenols,their preparation and pharmaceutical compositions containing them
IL63404A0 (en) Beta-lactams,their preparation and pharmaceutical compositions containing them